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The idea that active remodeling of glycerolipid acyl chains con-
tributes to the membrane transformations required for membrane 
trafficking is not new (Kozlov et al., 1989; Chernomordik et al., 
1995). However, identification of specific enzymes that execute 
such functions in living cells has proven elusive. Now, an interest-
ing study by Schmidt and Brown (see p. 211 of this issue) dem-
onstrates that a lysophosphatidic acid acyltransferase (LPAAT) is 
directly involved in regulating mammalian Golgi trafficking func-
tions. A variety of experimental approaches converge on a coher-
ent model where LPAAT3 quenches the formation of Golgi-derived 
tubules. In doing so, LPAAT3 opposes what is most likely a phos-
pholipase A2–mediated tubulation pathway. This balance of PLA2 
and LPAAT3 activities has functional consequences for mem-
brane trafficking from the mammalian Golgi complex.
Glycerolipids, such as phosphatidic acid (PtdOH), consist 
of a glycerol backbone to which three additional constituents are 
esterified. Fatty acyl chains are attached at the sn-1 and sn-2 posi-
tions, and these lend glycerolipids their hydrophobic character. 
The headgroup at the sn-3 position can be very simple (an OH 
group to generate diacylglycerol; DAG) or complex (i.e., another 
glycerolipid molecule). In the case of phospholipids, the head-
group is linked to the backbone by a phosphoester bond (PtdOH 
representing the simplest case). The three-dimensional shape of   
a phospholipid molecule (cone, inverted cone, cylinder) is gov-
erned by the ratio of the axial area of the headgroup to that of   
the acyl chain region. Because the sn-2 acyl chain is often un-
saturated, and therefore kinked, a suitably bulky headgroup is re-
quired to match the axial area of the acyl chain region and generate 
a cylindrical molecule that packs into orderly membrane bilayers. 
The basic principle is lipid shape can be regulated at the level of 
either the headgroup or the acyl chains, and enrichment of non-
cylindrical lipid molecules will physically deform membranes in 
predictable ways (Burger, 2000; Kooijman et al., 2005).
The role of lipid metabolic enzymes in Golgi membrane 
remodeling is a subject of intense interest. Now, in this 
issue, Schmidt and Brown (2009. J. Cell Biol. doi:10.1083/
jcb.200904147)  report  that  lysophosphatidic  acid– 
specific acyltransferase, LPAAT3, contributes to Golgi mem-
brane dynamics by suppressing tubule formation.
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Phospholipase A2 (PLA2) hydrolyzes the acyl chain from 
the sn-2 position of a glycerolipid molecule and, in doing so, 
generates a molecule with a glycerol backbone esterified to a 
fatty acid at sn-1 and to the headgroup at sn-3. This lyso-lipid 
exhibits a small axial area for the acyl chain region (and is 
shaped as an inverted cone that promotes positive membrane 
curvature). What LPAATs do is re-acylate the sn-2 position with 
a second fatty acid (or more accurately, a fatty acyl-CoA with 
release of CoA as product), often an unsaturated one in higher 
eukaryotes, so that the axial area of the acyl chain region is 
much  increased. When  the  headgroup  of  the  glycerolipid  is 
small,  as  is  the  case  with  PtdOH  and  DAG,  the  renovated   
glycerolipid molecule now assumes a cone shape that promotes 
negative membrane curvature. The general deacylation/reacylation 
cycle driven by sequential PLA2/LPAAT actions of this sort   
is termed the Lands cycle (Fig. 1; Lands and Hart, 1965).
Although originally discovered as a metabolic pathway for 
phospholipid acyl chain remodeling in liver, the Lands cycle 
now resurfaces as a mechanism for controlling mammalian Golgi 
membrane dynamics.
LPAATs have been studied previously from the perspec-
tive of the enzymology of lipid metabolism, but their functions 
from the cell biological point of view remain poorly under-
stood. The human genome sequence database identifies nine 
potential LPAATs (Leung, 2001; Shindou and Shimizu, 2009). 
A functional involvement of the Lands cycle (and LPAATs) 
with the Golgi complex was initially forecast by pharmacolog-
ical studies with PLA2 and LPAAT inhibitors—the former in-
sults interfering with various membrane trafficking pathways 
and the latter promoting others (de Figueiredo et al., 1998, 
2000; Drecktrah et al., 2003; Chambers et al., 2005). Unfortu-
nately, inhibitor studies of this sort are difficult to interpret. For 
instance, do the pleiotropic effects of the drugs report inhibi-
tion of multiple enzyme isoforms with various execution points, 
or are these reflections of “off-target” effects?
Schmidt and Brown (2009) now report the integral mem-
brane protein LPAAT3 localizes to ER/Golgi membranes and 
exhibits lyso-PtdOH acyltransferase activity. Modulation of 
LPAAT3 expression has significant consequences for Golgi or-
ganization and function. siRNA-mediated silencing of LPAAT3 
expression resulted in Golgi fragmentation into mini-stacks, an 
exquisite sensitivity of Golgi integrity to brefeldin A (BFA), and 
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fission-ogenic glycerolipid. DAG assumes even more extreme 
negative curvatures than does PtdOH, and it is not subject to 
electrostatic penalties associated with packing the highly nega-
tively charged PtdOH headgroup. Critical roles for DAG in 
Golgi membrane trafficking are well established (Kearns et al., 
1997; Baron and Malhotra, 2002; Fernandez-Ulibarri et al., 
2007; Asp et al., 2009).
How may proteins interface with the Lands cycle in the 
Golgi system? Do proteins provide the primary driving force 
for membrane deformation, or is lipid metabolism the major 
factor? It is unlikely to be solely the latter—at least in this 
case. Simple activity of PLA2 in generating lyso-PtdOH (or 
other lyso-lipids) is insufficient to impose significant positive 
curvature to membranes. The liberated fatty acid product will 
promote negative curvature—thereby countering the effects of 
the lyso-lipid. Enrichment of lyso-lipid into domains is a pre-
requisite for membrane deformation, and such enrichment can 
be reinforced by proteins in several ways. First, protein do-
mains that bend membranes (e.g., BAR-domains; Frost et al., 
2009) could bind lyso-lipids by virtue of their shape character-
istics  and  thereby  consolidate  them  into  positively  curved   
domains (Fig. 2). Second, coat or motor proteins that mechan-
ically generate tubules could drive a physical rearrangement 
of membrane lipids to structures that best fit their shape (Roux   
et al., 2005; Krauss et al., 2008; Sorre et al., 2009). In this sce-
nario, lyso-lipids re-sort preferentially to tubules and generate 
a  positive  feedback  loop  for  membrane  deformations  with 
positive curvature.
Reconstituted systems for membrane deformation use 
metabolically inert membranes, and are deprived of the active 
interface between lipid metabolism, proteins, and membrane 
dynamics. What blind spots are inherent in such protein-driven 
membrane deformation assays remains to be seen, but it will 
prove increasingly true that diverse pathways of lipid metabolism, 
elevated mis-localization of Golgi resident proteins to the ER. 
Reciprocally, elevated LPAAT3 expression retards Golgi col-
lapse into the ER upon BFA challenge. These various effects 
correlate with enhanced formation of Golgi-derived tubules   
in the face of LPAAT3 inhibitors (lyso-PtdOH formation fa-
vored) and depressed tubule biogenesis when LPAAT3 activity 
is increased (conversion of lyso-PtdOH to PtdOH favored).   
Tubulation is clearly relevant to membrane transport, as en-
hancement can (in specific cases) accelerate rates of cargo 
trafficking. Interference with tubule biogenesis, or maintenance, 
retards trafficking from the Golgi complex, and both anterograde 
and retrograde trafficking pathways are affected (Schmidt and 
Brown, 2009).
The simple physical principle that connects the Lands 
cycle to tubulation is that production of inverted cone lyso- 
PtdOH by a PLA2 strongly promotes positive membrane curva-
ture and tubulation, whereas LPAAT3-mediated reacylation of 
lyso-PtdOH to PtdOH has the opposite effect (Fig. 2). Curvature 
parameters have been measured for lyso-PtdOH and PtdOH at 
physiological salt and pH concentrations, and the respective 
spontaneous radii of curvatures are +20Å and 46Å, respec-
tively (for oleoyl molecular species; Kooijman et al., 2005). 
Interestingly, the measurements for lyso-PtdOH yield among 
the highest positive curvature values recorded to date. One test-
able question for future investigation is whether the PtdOH 
molecular species generated in Golgi membranes by LPAAT3 
differ  from  those  of  bulk  Golgi  membrane  PtdOH;  that  is, 
whether reacylation generates PtdOH molecular species with 
distinct properties such as unsaturated acyl chains at sn-2. Such 
a result would forecast an acyl-chain preference for LPAAT3 
and the resultant molecular species would assume more ex-
treme cone shapes that may contribute to the membrane trans-
formations that accompany fission processes (Burger, 2000; 
Kooijman et al., 2005). It is also possible that newly remodeled 
PtdOH is a precursor for DAG, which may be the operative 
Figure 1.  The Lands cycle. PLA2 hydrolyzes the acyl-chain from a glycero-
phospholipid to generate a free fatty acid and a lysophospholipid product. 
Reacylation of lysophospholipid back to a glycerophospholipid (often with 
a different acyl chain at sn-2) is catalyzed by an LPAAT and involves con-
sumption of a fatty acyl-CoA. This figure was adapted from Figure 5 in 
Shimizu (2009).
Figure 2.  Protein domains consolidate the positive membrane curvature 
generated by lyso-PtdOH. PLA2 hydrolyzes the acyl-chain from a phosphat-
idylcholine (PtdCho: cylindrical lipid) to generate a free fatty acid (FFA) and 
a lyso-PtdCho product (positive curvature). That lyso-PtdCho (LPC) species 
is further metabolized to lyso-PtdOH (LPA; greater positive curvature) by 
phospholipases with concomitant release of the choline (Cho) headgroup. 
The LPA is bound by proteins that “sense” curvature or bend membranes 
(e.g., BAR domain), leading to further sorting of LPA to the site of deforma-
tion (in this case a budding profile). LPAAT3 antagonizes this pathway by 
consuming lyso-PtdOH into PtdOH synthesis. The figure was adapted from 
one generously provided to V.A. Bankaitis by Wonhwa Cho (University of 
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including the Lands cycle, lubricate the actions of proteins in 
productive membrane deformation pathways. Which is more 
important—proteins or lipids—in this arena? Let’s call it an 
equal-opportunity collaboration.
Given the intense interest concerning interfaces of lipid 
metabolism and Golgi function, it is difficult to believe that the 
concept of lipid metabolism as an active participant in mem-
brane trafficking was ignored during the halcyon days when 
proteins involved in vesicle biogenesis were being discovered. 
Since  the  first  demonstrations  that  specific  lipid  metabolic 
pathways are central to these processes (Bankaitis et al, 1990; 
Cleves  et  al.,  1991),  work  from  numerous  laboratories  has 
greatly expanded the lipid–Golgi interface. The report of Schmidt 
and Brown (2009) adds new sets of activities to the ever-growing 
roster of lipid metabolic enzymes whose actions contribute   
to the remarkable Cirque du Soleil of Golgi membrane dynam-
ics. Indeed, we may soon wonder whether there is any such 
thing as a simple “housekeeping” lipid metabolic pathway in 
eukaryotic cells.
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